Search

La dermatomyosite est un type de maladie inflammatoire de la peau qui se caractérise par une inflammation des muscles (myosite) et des lésions cutanées caractéristiques. Epidémiologie La dermatomyosite est une affection qui touche à la fois les adultes et les enfants. Chez les... READ MORE

Le psoriasis est une affection cutanée qui touche 2% de la population. Des facteurs environnementaux et génétiques en sont responsables. Il peut être localisé ou extensif et le traitement peut être local (topique) ou systémique.     En plus du dermatologue qui est... READ MORE

Le psoriasis est une maladie dermatologique fréquente touchant 1 à 2% de la population mondiale. Elle est plus fréquente en Scandinavie et en Europe et affecte peu les races noire et chinoise. Elle est rare chez les amérindiens. C’est une dermatose inflammatoire dont le... READ MORE

La photothérapie se définit comme l’usage de la lumière dans le traitement d’une maladie. Déjà, dans les temps anciens, le psoriasis était déjà observé comme s’améliorant avec l’exposition solaire. Les rayons du soleil contiennent entre autres des Ultraviolets de type A et B (UVA... READ MORE

Dermatomyositis is is a type of inflammatory disease characterized by muscle weakness and a distinctive skin rash. Epidemiology Dermatomyositis is a condition which affects both adults and children. In adults, dermatomyositis usually occurs from the late 40s to early 60s, while... READ MORE

Ano ang soryasis? Ito ay isang kondisyon ng balat na may pamamaga. Ang mga selulang nakakalusot na sangkot sa pamamaga ay naghihikayat ng iba pang mga kalahok upang pagyamanin ang proseso ng pamamaga.     Ano ang mga pagkakataon ng pagkakaroon nito? Ang proporsyon ng... READ MORE

Have you heard about Lupus Erythematosus (LE)? This is an autoimmune disorder which is caused by antibodies against the nucleus of cells. They are usually found in women aged 20 to 50, but males can also be affected. It is a systemic disorder (affects the whole body) but it can... READ MORE

SAPHO syndrome is a rare clinical entity standing for: S: synovitis A: acne P: pustulosis H: hyperostosis O: osteitis     It was described by KAHN in 1994 and the following criteria are each sufficient for the diagnosis: chronic multifocal ostéomyelitis with or without... READ MORE

In deciding which therapy to use, many factors must be taken into consideration, including safety, efficacy, availability, and cost. Long-term side effects will, of course, become better known as experience with each therapy grows. In particular, biologic medications are already... READ MORE

Cost per responder of apremilast versus etanercept, adalimumab, and ustekinumab in Patients with moderate to severe psoriasis (Poster) Feldman SR et al AAD 2015 Annual Meeting, San Francisco CA – United States With the injected biologics treatment for psoriasis and the newer oral... READ MORE